Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0002064832-25-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-03 | 2025-12-02 | ENTA | Trout Harry R. III | See Remarks | S - Sale | $13.96 | -380 | 16.9K | -2% | -$5,305 | |
| 2025-12-03 | 2025-12-01 | ENTA | Trout Harry R. III | See Remarks | F - Tax | $14.12 | -105 | 17.3K | -0.6% | -$1,483 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-02 | S | D | 380 | $13.96 | 16,890 | D | — | — | (F2) Represents shares sold by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 27, 2024, as required pursuant to the terms of the award. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. |
| 2 | Common | Common Stock | 2025-12-01 | F | D | 105 | $14.12 | 17,270 | D | — | — | (F1) Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 19, 2021. |